CRANEWARE PLC

Notice of Dividend Amount • Nov 29, 2024

National Storage Mechanism | Additional information

RNS Number : 2488O

Craneware plc

29 November 2024

Craneware plc

("Craneware" or the "Company" or the "Group")

Dividend Currency Election

29 November 2024 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, today gives further information regarding its final dividend announced on 3 September 2024.

For those shareholders who have previously registered to receive their dividend in US dollars under the Company's Dividend Currency Election, the dividend will be paid at an exchange rate of $1.26.

For further information, please contact:

Craneware plc	+44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Alma Strategic Communications (Financial PR)	+44 (0)20 3405 0205
Caroline Forde, Kinvara Verdon, Sarah Peters	craneware@ almastrategic.com
Peel Hunt (NOMAD and Joint Broker)	+44 (0)20 7418 8900
Neil Patel, Benjamin Cryer, Kate Bannatyne
Investec Bank PLC (Joint Broker)	+44 (0)20 7597 5970
Patrick Robb, Virginia Bull, Shalin Bhamra
Berenberg (Joint Broker)	+44 (0)20 3207 7800
Mark Whitmore, Richard Andrews, Dan Gee-Summons

About Craneware

The Craneware Group (AIM:CRW.L), is the market leader in value cycle solutions. For 25 years, we have collaborated with U.S. healthcare providers to optimize revenue integrity, pricing intelligence, decision support, labor productivity, business of pharmacy, and 340B program management. 

Customers choose Trisus®, a HITRUST- and SOC2 Type II-certified, SaaS platform, to achieve operational and financial excellence in pursuit of their healthcare mission - delivering quality care to their communities. The Craneware Group - Transforming the Business of Healthcare.

Learn more at www.thecranewaregroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEAKFNAFSLFFA